MedPath

白城市亿正药业有限公司

Ownership
-
Established
2001-11-19
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

32

NMPA:32

Drug Approvals

Compound Aminopyrine Phenacetin Tablets

Product Name
去痛片
Approval Number
国药准字H22021734
Approval Date
Apr 10, 2020
NMPA

Compound Theophylline and Ephedrine Tablets

Product Name
复方茶碱麻黄碱片
Approval Number
国药准字H22025992
Approval Date
Apr 10, 2020
NMPA

Metamizole Sodium Tablets

Product Name
安乃近片
Approval Number
国药准字H22021729
Approval Date
Apr 10, 2020
NMPA

Piracetam Capsules

Product Name
吡拉西坦胶囊
Approval Number
国药准字H22025474
Approval Date
Apr 10, 2020
NMPA

Berberine Hydrochloride Tablets

Product Name
盐酸小檗碱片
Approval Number
国药准字H22021737
Approval Date
Apr 10, 2020
NMPA

Metamizole Sodium Tablets

Product Name
安乃近片
Approval Number
国药准字H22021730
Approval Date
Apr 10, 2020
NMPA

Compound Sulfamethoxazole Tablets

Product Name
复方磺胺甲噁唑片
Approval Number
国药准字H22021556
Approval Date
Apr 10, 2020
NMPA

Metronidazole Tablets

Product Name
甲硝唑片
Approval Number
国药准字H22021523
Approval Date
Apr 10, 2020
NMPA

Cimetidine Tablets

Product Name
西咪替丁片
Approval Number
国药准字H22024983
Approval Date
Apr 10, 2020
NMPA

Paracetamol,Caffein,Atificial Cow-bezoar and chlorphenamine Maleate capsules

Product Name
氨咖黄敏胶囊
Approval Number
国药准字H22024350
Approval Date
Apr 10, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.